Zilretta

Zilretta Now Available for Osteoarthritis Knee Pain

Zilretta Now Available for Osteoarthritis Knee Pain

By

Flexion Therapeutics announced the availability of Zilretta (triamcinolone acetonide extended-release injectable suspension) indicated for the management of pain associated with osteoarthritis (OA) of the knee.

FDA Approves Zilretta NDA for Knee Osteoarthritis

FDA Approves Zilretta NDA for Knee Osteoarthritis

The Food and Drug Administration has accepted for review the New Drug Application for Zilretta for the treatment of patients with osteoarthritis of the knee.

Sign Up for Free e-Newsletters